Repare Therapeutics is developing precision oncology drugs for patients that target specific vulnerabilities of tumor cells. The company's approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality.
Company (Alive / Active)
Saint-Laurent, H4S 2A1
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)